MedPath

Sentraflox AM-10

These highlights do not include all the information needed to use fluoxetine capsules USP safely and effectively. See full prescribing information for fluoxetine capsules USP. Initial U.S. Approval: 1987

Approved
Approval ID

35fee753-acd7-4da2-bd60-973dc6c0b21f

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 17, 2011

Manufacturers
FDA

Physician Therapeutics LLC

DUNS: 931940964

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

FLUOXETINE HYDROCHLORIDE, CHOLINE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68405-022
Product Classification
G
Generic Name
FLUOXETINE HYDROCHLORIDE, CHOLINE
Product Specifications
Effective DateAugust 10, 2011
FDA Product Classification

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Sentraflox AM-10 - FDA Drug Approval Details